FOXE1 and neoplasm: In addition to the identified FOXE1 germline variants, we performed next-generation sequencing (NGS) of the F1 and F2 probands’ leukocyte and tumour nucleic acids to investigate whether additional molecular alterations could be involved in the initiation/progression of these patients’ tumours.